Steven Nathan

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Boehringer-Ingelheim
    Topic:
    ILD
    Date added:
    07/12/2023
    Date updated:
    09/20/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    United Therapeutics
    Topic:
    ILD and PH
    Date added:
    07/12/2023
    Date updated:
    09/20/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Merck
    Topic:
    COPD and PH
    Date added:
    07/12/2023
    Date updated:
    09/20/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Daewoong
    Topic:
    IPF
    Date added:
    07/12/2023
    Date updated:
    09/20/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Trevi Therapeutics
    Topic:
    IPF
    Date added:
    07/12/2023
    Date updated:
    09/20/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Roivant
    Topic:
    ILD and PH
    Date added:
    07/12/2023
    Date updated:
    09/20/2024
    Relationship end date:
    12/31/2023
Return to 2023 Inova Pulmonary Hypertension Day